|
Long-Term Care
|
E02.760.476 |
|
|
Clinical Chemistry Tests
|
D019963 |
[Laboratory tests demonstrating the presence of physiologically significant substances in the blood, urine, tissue, and body fluids with application to the diagnosis or therapy of disease.
] |
|
Central Nervous System Stimulants
|
D27.505.954.427.220 |
|
|
Mood Disorders
|
D019964 |
[Those disorders that have a disturbance in mood as their predominant feature.
] |
|
Toll-Like Receptors
|
D12.776.543.750.705.910.500 |
|
|
Receptors, Pattern Recognition
|
D12.776.543.750.705.910 |
|
|
Zona Pellucida
|
A16.690.900 |
|
|
Enzymes, Immobilized
|
D08.811.180 |
|
|
Berkelium
|
D01.552.544.075 |
|
|
Pivampicillin
|
D03.633.100.300.750.750.050.700 |
|
|
Admitting Department, Hospital
|
N02.278.216.500.968.040 |
|
|
Aldehyde Oxidoreductases
|
D08.811.682.657.163 |
|
|
Oxidoreductases Acting on Aldehyde or Oxo Group Donors
|
D08.811.682.657 |
|
|
Transcription Factors, TFIII
|
D12.776.260.775.937 |
|
|
Soybean Oil
|
D20.215.784.750.880 |
|
|
Fluorescent Treponemal Antibody-Absorption Test
|
E05.200.812.735.850.200 |
|
|
Syphilis Serodiagnosis
|
E05.200.812.735.850 |
|
|
Thapsia
|
B01.650.940.800.575.912.250.075.937 |
|
|
Protein Structural Elements
|
G02.111.570.820.709.275 |
|
|
Protein Conformation
|
G02.111.570.820.709 |
|
